DIAGNOS (CVE:ADK) Stock Price Down 9.2%

Shares of DIAGNOS Inc. (CVE:ADK) were down 9.2% during trading on Monday . The company traded as low as C$0.35 and last traded at C$0.35. Approximately 109,454 shares changed hands during mid-day trading, an increase of 19% from the average daily volume of 92,220 shares. The stock had previously closed at C$0.38.

Wall Street Analyst Weigh In

Separately, Ventum Cap Mkts upgraded DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.

DIAGNOS Trading Down 9.2 %

The business’s 50-day simple moving average is C$0.33 and its two-hundred day simple moving average is C$0.31. The firm has a market capitalization of C$28.10 million, a price-to-earnings ratio of -8.63 and a beta of -0.44. The company has a quick ratio of 0.68, a current ratio of 0.39 and a debt-to-equity ratio of 245.28.

DIAGNOS (CVE:ADK) last announced its earnings results on Wednesday, August 21st. The company reported C($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The firm had revenue of C$0.04 million during the quarter, compared to analysts’ expectations of C$0.07 million. Equities analysts forecast that DIAGNOS Inc. will post -0.02 earnings per share for the current year.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.